undefined Stock News
GuruFocus News Biotechnology
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Amylyx Pharmaceuticals Inc (AMLX) showcases promising clinical progress and a strong cash position, despite facing revenue shortfalls and regulatory hurdles. Nov 08, 2024
GuruFocus News Biotechnology
Ascelia Pharma AB (FRA:7ZA) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Resilience
Ascelia Pharma AB (FRA:7ZA) reports a strong cash position and significant progress in clinical trials, despite facing challenges in NDA submission and commercialization partnerships. Nov 08, 2024